IGMS Company Profile and Key Details
IGM Biosciences, Inc.
IGMS Stock Price Chart
Stock Price Today
IGM Biosciences, Inc. (IGMS) stock surged +2.23%, trading at $1.61 on NASDAQ, up from the previous close of $1.57. The stock opened at $1.55, fluctuating between $1.55 and $1.67 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non-Hodgkin's lymphoma (NHL). It is also developing IGM-8444, an IgM antibody, which is in Phase 1 clinical trials for the treatment of patients with solid cancers; and IGM-7354, an anti-PD-L1 IgM antibody for the treatment of patients with solid and hematologic malignancies; IGM-2644, a bispecific T cell engaging IgM antibody targeting CD38 and CD3 proteins for the treatment of patients with multiple myeloma; and IGM-2537, a bispecific T cell engaging IgM antibody targeting CD123 and CD3 proteins for the treatment of patients with acute myeloid leukemia, myelodysplastic syndromes, and acute lymphoblastic leukemia. It has a collaboration and license agreement with Genzyme Corporation to generate, develop, manufacture, and commercialize IgM antibodies. The company was formerly known as Palingen, Inc. and changed its name to IGM Biosciences, Inc. in 2010. IGM Biosciences, Inc. was incorporated in 1993 and is headquartered in Mountain View, California.
Company Information
| Employees | 198 |
| Beta | 0.19 |
| Sales or Revenue | $2.13M |
| 5Y Sales Change% | 0% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Biotechnology |
Frequently Asked Questions
IGM Biosciences, Inc. (NASDAQ: IGMS) stock price is $1.61 in the last trading session. During the trading session, IGMS stock reached the peak price of $1.67 while $1.55 was the lowest point it dropped to. The percentage change in IGMS stock occurred in the recent session was 2.23% while the dollar amount for the price change in IGMS stock was $0.04.
The NASDAQ listed IGMS is part of Biotechnology industry that operates in the broader Healthcare sector. IGM Biosciences, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Dr. Angus M. Sinclair Ph.D.
Senior Vice President of Immuno-Oncology
Dr. Lisa L. Decker Ph.D.
Chief Bus. Officer
Mr. Fred M. Schwarzer J.D.
Chief Executive Officer, Pres & Director
Mr. Paul C. Graffagnino
Vice President of Legal Affairs
Ms. Suzette Tauber
Chief HR Officer
Dr. Bruce A. Keyt
Chief Scientific Officer
Mr. Steven Weber
Senior Vice President, Corporation Controller & Principal Accounting Officer
Dr. Chris H. Takimoto FACP, M.D., Ph.D.
Chief Medical Officer
Mr. Misbah Tahir
Chief Financial Officer
Mr. TS Harigopal
Senior Vice President of Group Operations
Dr. Shinyu Chen M.D., Ph.D.
Consultant
IGMS's closing price is 14.6% higher than its 52-week low of $1.37 where as its distance from 52-week high of $22.50 is -93.02%.
Number of IGMS employees currently stands at 198.
Official Website of IGMS is: https://igmbio.com
IGMS could be contacted at phone 650 965 7873 and can also be accessed through its website. IGMS operates from 325 East Middlefield Road, Mountain View, CA 94043, United States.
IGMS stock volume for the day was 112.58K shares. The average number of IGMS shares traded daily for last 3 months was 478.92K.
The market value of IGMS currently stands at $95.44M with its latest stock price at $1.61 and 59.46M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com